SGHT Sight Sciences
- 6.400
- -0.050-0.78%
Sight Sciences News
Sight Sciences Announces the Release of Its First Sustainability Report
Sight Sciences (NASDAQ:SGHT) Has Debt But No Earnings; Should You Worry?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We can see that Sight Sciences, Inc. (NASDAQ:SGHT) does use debt in its business. But the real question is whether this debt is making the company risky.
Predictive Oncology, Augmedix, Cue Health Among Healthcare Movers
Express News | Sight Sciences Announces Publication Of Twelve-Month Results Of SAHARA RCT Data Demonstrating Improved Signs And Symptoms Of Dry Eye Disease For TearCare Patients Crossed Over FFom Restasis
Express News | Sight Sciences Announces the Publication of Twelve-Month Results of the Sahara Rct Demonstrating Improved Signs and Symptoms of Dry Eye Disease for Tearcare Patients Crossed Over From Restasis
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating...
Sight Sciences' Study Of OMNI System In Advanced Glaucoma Reports Positive Outcome
Express News | Sight Sciences Published Results Of ROMEO Study Data In Journal Clinical Opthalmology
Sight Sciences Announces Publication of a New Analysis From The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved With OMNI Across Mild, Moderate, and Advanced Glaucoma
MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
Sight Sciences(SGHT.US) Officer Sells US$70,869.98 in Common Stock
$Sight Sciences(SGHT.US)$ Officer Bauerlein Alison sold 13,066 shares of common stock on May 17, 2024 at an average price of $5.424 for a total value of $70,869.98.Source: Announcement What is stateme
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
Sight Sciences | 10-Q: Quarterly report
Sight Sciences, Inc. (NASDAQ:SGHT) Analysts Are Pretty Bullish On The Stock After Recent Results
Shareholders of Sight Sciences, Inc. (NASDAQ:SGHT) will be pleased this week, given that the stock price is up 13% to US$5.96 following its latest first-quarter results. Revenue of US$19m came i
Earnings Call Summary | Sight Sciences(SGHT.US) Q1 2024 Earnings Conference
The following is a summary of the Sight Sciences, Inc. (SGHT) Q1 2024 Earnings Call Transcript:Financial Performance:Sight Sciences reported Q1 2024 revenue of $19.3 million, a record for their first
Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed
Sight Sciences (SGHT) shares were up nearly 4%, a day after the company reported narrower Q1 loss and revenue that exceeded consensus. The company reported Q1 net loss Thursday of $0.33 per diluted sh
Express News | Piper Sandler Reiterates Neutral on Sight Sciences, Raises Price Target to $6
Piper Sandler Sticks to Their Hold Rating for Sight Sciences (SGHT)
Express News | Sight Sciences Inc : Citigroup Raises Target Price to $6 From $5.5
Sight Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 — Needham Reiterates → Hold 04/10/2024 — Needham Reiterates → Hold 03/08/2024 24.78% Stifel $
Analysis
Price Target
No Data
